CUSIP 746964105COMQTTBQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
52 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Orbimed Advisors LLC | 2.25M | $7.48M | 0 | Held |
| 2 | Atlas Venture Life Science Advisors, LLC | 2.09M | $6.95M | 0 | Held |
| 3 | Carlyle Group Inc. | 1.10M | $3.62M | 0 | Held |
| 4 | Acorn Capital Advisors, LLC | 493.4K | $1.64M |
| −310.0K |
| Reduced |
| 5 | Vanguard Group Inc | 321.1K | $1.07M | +25.6K | Added |
| 6 | Arch Venture Management, LLC | 320.5K | $1.06M | 0 | Held |
| 7 | Pfizer Inc | 277.8K | $922.2K | 0 | Held |
| 8 | Sanofi | 244.1K | $810.4K | 0 | Held |
| 9 | Opaleye Management Inc. | 213.4K | $708.4K | +213.4K | New |
| 10 | Geode Capital Management, LLC | 106.1K | $352.4K | +17.6K | Added |
See every fund holding Q32 Bio Inc, with full quarter-over-quarter share changes.
Unlock all holders